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Modular bioink for 3D printing of biocompatible hydrogels: sol-gel 
polymerization of hybrid peptides and polymers 
C. Echalier,a,b R. Levatoc, M.A. Mateos-Timoneda c,f, O. Castañoc, S. Déjeana, X. Garric,a C. Pinese,a 
D. Noël,d E. Engel,c J. Martinez,a A. Mehdi,b* and G. Subraa* 
An unprecedented generic system allowing the 3D printing of 
peptide-functionalized hydrogels by soft sol-gel inorganic 
polymerization is presented. Hybrid silylated inorganic/bioorganic 
blocks are mixed in biological buffer in an appropriate ratio, to 
yield a multicomponent bioink that can be printed as a hydrogel 
without using any photochemical or organic reagent. Hydrolysis 
and condensation of the silylated precursors occur during the 
printing process and result in a covalent network in which 
molecules are linked through siloxane bonds. The viscosity of the 
colloidal solution used as bioink was monitored in order to set up 
the optimal conditions for extrusion printing. Grid-patterned 
hydrogel scaffolds containing hybrid integrin ligand were printed 
using a pressure-driven rapid prototyping machine. Finally, they 
were seeded with mesenchymal stem cells, demonstrating their 
suitability for cell culture. The versatility of the sol-gel process and 
its biocompatibility makes this approach highly promising for the 
preparation of tailor-made cell-laden scaffolds. 
 
3D printing raised high hopes in regenerative medicine, 
enabling the on-demand design of structurally complex 
scaffolds for tissue regeneration. Due to their high content in 
water, hydrogels are highly attractive biomaterials for 3D 
printing as efficient extracellular matrix surrogates.1–3 
Extrusion, due to the affordability of commercially available 3D 
printers, and the compatibility with a large number of 
polymers, has emerged as a method of choice for rapid 
fabrication of hydrogel constructs.4 It is one of the most 
straightforward methods for biofabrication: a continuous 
filament of hydrogel is extruded while the x/y/z movement of 
the printhead enables to craft the desired shape. Blueprints 
from a CAD file are constructed into 3D architectures in a 
layer-by-layer fashion. The bioink contains the hydrogel 
precursors and has to be carefully chosen to avoid premature 
collapse of the printed structure.  
 Various types of physical and chemical hydrogels have 
been tailored to address this challenge.3 Among physical 
hydrogels, self-assembling peptide hydrogels are very 
promising for in vivo applications.5,6 They can be injected 
thanks to their shear-thinning behavior and are degraded by 
proteolytic enzymes, yielding non-toxic amino acids and short 
peptides as metabolites. However, although widely used as 
drug delivery systems,7 such hydrogels are less favoured for 
biofabrication as their network only relies on weak non-
covalent interactions which impacts their stability and 
structural integrity when placed in contact with biological 
fluids and extracellular matrices. The main class of materials 
used for biofabrication remains chemical hydrogels based on 
natural or synthetic polymers.3 The control of gelation is of 
high importance and constitutes the main limitation in the 
panel of polymers that are used. To prevent the spreading of 
hydrogel after printing, the viscosity has to be precisely 
controlled. This entails the careful handling of a pre-polymer 
solution, which has to gelate quickly enough upon deposition 
on the printing platform. Biopolymers have their own gelation 
methods such as complexation of calcium ions for alginate,8 
pH adjustment of an acidic solution for collagen,9 and cooling a 
hot viscous solution for agarose,10 to name a few. One of the 
concerns about biopolymer is the batch-to-batch 
reproducibility impacting the gelation kinetics. Cross-linking of 
soluble polymer was generally employed to increase the 
stability of the hydrogel. For example, methacrylate groups 
introduced on biopolymers are commonly used for that 
purpose, reacting with sulfhydryl containing cross-linkers11 
through a Michael-type addition. They may also be used for 
photo cross-linking.12 Diels alders reaction between furan-
modified gelatin and maleimide cross-linkers,13 hydrazone 
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formation between aldehyde-modified alginate and hydrazide 
cross-linkers14 as well as copper-free azide-alkyne 
cycloaddition15,16 were also investigated. The range of cross-
linking strategies is even wider for hydrogels prepared from 
synthetic polymers. Photo cross-linking remains the most 
commonly used method,171819 the transparency of the material 
enabling an efficient curing process. The bioink, which contains 
soluble functionalized polymers or monomers and 
photoinitiators, is UV-irradiated. This can be done while the 
bioink is flowing out of the nozzle or after printing. 
Polyhydroxyethylmethacrylate (PHEMA)20 and polyacrylamide 
(PA)21 scaffolds have been printed by this way. 
 
 In this study, we propose a novel methodology to 3D print 
chemically cross-linked hydrogels by using the sol-gel process. 
To the best of our knowledge, sol-gel was never exploited for 
biofabrication with hydrogel inks. All examples combining sol-
gel and 3D printing deal either with inorganic pattern direct 
writing22 or with ink-jet printing or extrusion under non-
biocompatible conditions.23,24 In Orsi et al.‘s work, silane-
modified polymers were pre-hydrolysed and used as printable 
inks. Gel formation was promoted by Si-O-Si formation upon 
solvent evaporation.23 Chiappone et al. printed 3D structured 
hybrid materials using both photopolymerization and sol-gel 
process. The photopolymerization led to the formation of an 
organic network during the printing step while the inorganic 
network resulted from the sol-gel process performed after 
printing, under conditions non-compatible with live cells.24 In 
contrast, the bioink we have developed enables printing at 
room temperature, in physiological buffer (pH 7.2), without 
photoactivation or additional chemical reagents. An 
alkoxysilane-derivatized synthetic polymer (Figure 1, bi-
functional hybrid PEG 1) solubilized in DPBS undergoes 
hydrolysis and condensation in the course of the printing 
process, yielding a covalent hydrogel (Figure 1).  
 
Fig. 1 Principle of sol-gel extrusion printing of hybrid functional hydrogels. Hybrid 
silylated polymers and bioactive peptides are mixed in a cell-friendly buffer to 
yield a multicomponent bioink. These hybrid precursors undergo condensation 
while the bioink is 3D printed to produce hydrogel scaffolds. 
 
 To succeed in an efficient cell colonization of artificial 
materials and its progressive replacement with natural 
matrices, cells seeded in the artificial substrate have to 
differentiate, to migrate and to behave like in their natural 
environment. This can be induced by diverse biochemical (e.g. 
growth factors, cell-adhesion peptide ligands) and physical 
(e.g. pore size, stiffness, rigidity) stimuli distributed within the 
tissues.25 The sol-gel approach presented in this study is highly 
attractive since its modularity simplifies the covalent 
modification of the hydrogel with peptide ligands exhibiting 
biological activities (i.e. enhancing cell adhesion, stimulating 
proliferation; etc.). This is a significant breakthrough in this 
technology, since available 3D printable synthetic polymers 
such as PEG, PHEMA or PA are not ideal supports as such for 
cell attachment and have to be further functionalized to 
improve their cell compatibility.20,26,27 Interestingly, sol-gel 
could simplify the biofabrication of hydrogel scaffolds of 
heterogenous composition. Indeed, as a single chemistry 
system is involved, different bioinks can be prepared to 
sequentially print layers with different compositions in 
bioactive components, eliciting specific cell responses in a 
spatially controlled environment. 
We recently demonstrated the feasibility of the sol-gel 
approach to obtain functional PEG-based hydrogels with either 
antibacterial or cell-adhesive properties, depending on the 
hybrid peptide that was used.28 We thus determined a 
hydrogel composition suitable for cell adhesion which included 
hybrid RGDSP ligand 2 which displays a trialkoxysilane function 
at its N-terminus. Once homogeneously mixed in the bioink at 
the chosen concentration, hybrid blocks (1 and 2) reacted 
together chemoselectively to form Si-O-Si bonds, guaranteeing 
both the desired orientation and the correct density of 
bioactive ligand within the hydrogel matrix.  
 After solubilization of the hybrid silylated precursors 1 and 
2 in DPBS, the sol-gel process started with a constant increase 
of the bioink viscosity. First of all, the progress of sol-gel 
reaction (i.e. hydrolysis and condensation) was monitored by 
viscometry. The bioink viscosity was measured as a function of 
time in order to precisely determine when the bioink could be 
printed. To do so, a 10 wt% hybrid PEG 1 solution in DPBS 
containing 0.3 wt% of NaF was prepared and poured into the 
sample cup of sine-wave vibro viscometer SV-10 (A&D). This 
apparatus measures the viscosity by detecting the driving 
electric current necessary to resonate two sensor plates at a 
constant frequency. Its wide measurement range was well 
suited to follow the gelation process without damaging the 
hydrogel. The viscosity of the solution was recorded at 37 °C 
(Figure 2) until it reached 10 000 mPa.s, which was the highest 
value measurable with the apparatus. At the beginning of the 
experiment, the viscosity of the solution was quite low, around 
1.5 mPa.s. It increased negligibly for the first two hours when 
hydrolysis occurred and condensation started. The gel point 
was observed at 120 min. Afterwards the viscosity increased 
sharply. We found that printing should be performed when 
hydrogel viscosity was comprised between 2 000 and 5 000 
mPa.s: below 2 000 mPa.s, the hydrogel tended to spread, 
whereas above 5 000 mPa.s, a continuous filament could not 
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be extruded. More precisely, a viscosity between 2 500 and 4 
500 mPa.s was ideal for a neat deposition of the hydrogel and 
was consequently selected for further studies. In order to 
maintain the hydrogel in the appropriate viscosity range for a 
prolonged period, we investigated printing at room 
temperature. After gelation occurred at 37 °C, the 
temperature was lowered to 25 °C to slow down the sol-gel 
process. The viscosity was recorded in these conditions (Figure 
2). This change in temperature allowed widening the printing 
time window from 1 to 2 hours. As already pointed out, one 
objective of this work was to print RGD-functionalized 
scaffolds. So the hybrid GRGDSP ligand 2 (20 mol% in regards 
to 1, 1 wt% in regards to the solvent) was added to the hybrid 
PEG 1 solution, and the influence on viscosity evolution was 
studied (Figure 2). One can notice that gelation was faster with 
the hybrid GRGDSP 2, gel point was observed at 84 min that is 
to say 36 min earlier. Nonetheless, the presence of the hybrid 
RGD 2 did not seem to induce any change in the final viscosity 
and still allowed printing in the same range of viscosity (2 500 
– 4 500 mPa.s) within a 2 hour time frame. 
 
 Fig. 2 Viscosity of the hybrid solutions recorded as a function of time. Dashed 
grey line: hybrid PEG solution at 37°C; solid grey line: hybrid PEG solution at 37°C 
until gel point and then at 25°C; black line: hybrid PEG-GRGDSP solution at 37°C 
until gel point and then at 25°C. 
 
All the printing assays were performed on an nScrypt 3Dn-300-
TE rapid prototyping machine (nScrypt, Orlando, FL). This 3D 
dispensing machine pneumatically deposits a bioink to build up 
scaffolds layer by layer on a stationary platform. The bioink 
was prepared by solubilization of the hybrid PEG 1 (10 wt%) 
and the hybrid GRGDSP peptide 2 (1 wt%) in DPBS containing 
NaF (0.3 wt%). It was loaded in a 3 mL syringe (fluid dispensing 
system Nordson EFD) equipped with an air pressure-driven 
piston. The syringe was incubated at 37 °C until gelation 
occurred (84 min). Then, it was kept at room temperature (25 
°C) for 76 min. The bioink reached the appropriate viscosity for 
printing (2500 mPa.s) 160 min after the beginning of the sol-
gel process. At this point, the syringe was fitted with a 27 G 
conical nozzle (Nordson EFD). A pressure comprised between 
0.15 and 0.28 MPa was applied over the piston to dispense the 
hydrogel. It was tuned to be consistent with the increasing 
viscosity. A grid pattern was chosen. The scaffold design was a 
5 layer stack of porous 13.5 mm squares with 0.9 mm strand 
spacing (Figure 3). The deposition of the first layer was crucial 
for the scaffolding. In order to make the first strands stick and 
stay in place, glass slides were coated with a thin layer of 
bioink before printing. Porous 3D scaffolds were successfully 
printed as the printhead moved at a constant speed of 3 mm/s 
in the xy plane.  
 
Fig. 3 Stereomicroscopy images of the 3D-printed scaffolds. (A,B) top views; (C,D) 
side views. All the scale bars represent 1 mm. 
 
 The biocompatibility of the 3D printed scaffolds was 
assessed on mouse mesenchymal stem cells (mMSC). This cell 
line was chosen in the perspective of tissue engineering 
applications. After printing, the scaffolds were stored in their 
wet state (in a humidified environment). Since the printing 
environment was not sterile, the scaffolds were sterilized in an 
autoclave. It is worth noting that this type of treatment has 
already been used on hybrid materials to drive sol-gel 
reactions to completeness.29 After this treatment, the scaffolds 
proved to be stable for at least two weeks in DPBS buffer. 
Autoclaved scaffolds were allowed to swell in cell culture 
medium before being cut into discs of 7 mm in diameter The 
printed hydrogels were immersed in a cell suspension to 
undergo a dynamic cell seeding procedure at 37 °C, in a 
rotating device. Then, the cell-laden constructs were washed 
with cell culture media and placed in polypropylene tubes 
filled with media. After 4 days of proliferation, a Live/Dead 
assay was performed on the scaffolds. Upon observation with 
a fluorescent microscope, live cells appeared in green whereas 
dead cells were marked in red (Figure 4). These results were 
compared to cells cultured on a PLA scaffold under the same 
conditions (ESI† Fig. S6). Excellent cell viability was observed in 
both cases, indicating that the hybrid PEG-peptide 3D scaffolds 
were suitable for cell culture. 
Conclusions 
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Fig. 4 Fluorescent microscopy images of mMSC after 4 days of culture on a hybrid 3D-printed scaffold. (A) transmitted light image; (B) calcein-AM stain showing 
live cells in green; (C) EthD-III stain showing dead cells in red; (D) merged images.  
 
 Beyond the printing of hydrogel scaffolds made out of 
hybrid PEG and hybrid integrin ligand, the combination of sol-
gel chemistry and 3D extrusion printing paves the way to 
unlimited customization of biomimetic matrices. The 
functionalization of (bio)polymers and small molecules, in 
particular bioactive peptides, with silyl groups enables 
formation of the desired network in water, using a single soft 
chemoselective chemistry. Proceeding at room temperature in 
biological buffer with mild pressure constraint, this process 
could be a promising way to prepare cell-laden scaffolds.  
 
Moreover, the combination of several syringes filled with 
different hybrid bioinks is envisioned to open the way to the 
biofabrication of multilayer and non-homogeneous 
biomaterials, mimicking even more closely the complexity of 
natural tissues in terms of shape and biochemical composition. 
Experimental section 
§ Hybrid PEG and hybrid peptide syntheses: the synthesis of 
hybrid blocks was achieved using 3-
isocyanatopropyltriethoxysilane following a previously described 
procedure.28 
§ Preparation of the bioink: hybrid PEG 1 (10 wt%, 300 mg) and 
hybrid GRGDSP peptide 2 (1 wt%, 30 mg) were dissolved in DPBS 
(3 mL) containing sodium fluoride (0.3 wt%, 9 mg). 
§ 3D printing: 3D printing was performed on an nScript rapid 
prototyping machine (3Dn-300-TE) at RT using a 3 mL syringe 
filled with the bioink and fitted with a 200 µm tip. The hydrogel 
was dispensed on a glass slide at a constant speed of 3 mm.s-1 
under a pressure ranging from 0.15 to 0.28 MPa. 
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